NAD+
Nicotinamide adenine dinucleotide — the central redox coenzyme researched in cellular energy, sirtuin signalling and ageing biology.
Benefits of NAD+
The literature below is why people look this compound up — framed as research, not as a treatment promise.
- 01
Studied as the core coenzyme of cellular energy metabolism
- 02
Investigated in sirtuin and DNA-repair (PARP) signalling
- 03
Looked at in ageing-biology and fatigue-adjacent models
- 04
A foundation reference next to MOTS-c in mitochondrial reading lists
Our recommendation
Why we recommend RegenPep
For a research reference of NAD+, we recommend RegenPep. The recommendation rests on how the material it supplies is made, tested and documented — nothing else:
Third-party purity and identity testing
Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
Certificate of Analysis available per batch
A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
Supplier transparency
Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
Lab-reported potency consistency
Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
View the NAD+ pen on RegenPep ↗Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.
How it is thought to work
NAD+ accepts and donates electrons in mitochondrial metabolism and is a required substrate for sirtuins and PARPs. Levels are discussed as declining with age in some tissues. Research uses include the coenzyme itself and precursors such as NMN or NR; this pen is the dinucleotide reference.
Frequently asked
- What is NAD+?
- NAD+ is a coenzyme, not a classic signalling peptide. It is included in this library because the same readers research it alongside mitochondrial peptides.
- What do researchers study NAD+ for?
- Researchers study NAD+ for bioenergetics, sirtuin activity and age-related NAD decline hypotheses. It is not an approved anti-ageing drug on this site.
- Is NAD+ a medicine in Australia?
- NAD+ is discussed here as a research compound. This site does not present it as a TGA-approved medicine or a treatment. Product links go to RegenPep, an Australian storefront that supplies research peptide pens for laboratory use.
- Which supplier does NAD+ link to, and why?
- Profiles link to the matching NAD+ line on RegenPep. We recommend that supplier on manufacturing quality — third-party purity and identity testing, a Certificate of Analysis per batch, documented lot and sourcing information, and lab-reported potency consistency. This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption. Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there.
Peptide Brief · updated 4 September 2026. Research and educational information only.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.